ADMA BIOLOGICS, INC. Increase (Decrease) in Deferred Revenue
ADMA BIOLOGICS, INC. (ADMA) reported Increase (Decrease) in Deferred Revenue of $0 for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2020-11-05
- ADMA BIOLOGICS, INC. increase (decrease) in deferred revenue for the quarter ending 2016-12-31 was $0.00.
- ADMA BIOLOGICS, INC. increase (decrease) in deferred revenue for the quarter ending 2015-12-31 was $0.00.
- ADMA BIOLOGICS, INC. increase (decrease) in deferred revenue for the quarter ending 2014-12-31 was $0.00.
- ADMA BIOLOGICS, INC. increase (decrease) in deferred revenue for the quarter ending 2013-12-31 was $0.00.
- ADMA BIOLOGICS, INC. increase (decrease) in deferred revenue for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- ADMA BIOLOGICS, INC. increase (decrease) in deferred revenue for fiscal 2015 was $1.52M.
- ADMA BIOLOGICS, INC. increase (decrease) in deferred revenue for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- ADMA BIOLOGICS, INC. increase (decrease) in deferred revenue for fiscal 2013 was $1.70M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 | |||
| 2019-09-30 | $1.06M 10-Q · filed 2020-11-05 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-06 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $0.00 10-K · filed 2017-02-24 | ||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-10 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $1.52M 10-K · filed 2017-02-24 | ||
| 2015-09-30 | $1.52M 10-Q · filed 2016-11-10 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $0.00 10-K · filed 2016-03-23 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-10 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $0.00 derived: sum of 2 quarters · filed 2015-03-09 | $1.70M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $1.70M 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | $1.70M 10-Q · filed 2014-08-11 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |